Google’s New AI-Powered Ad Formats in Search: What Marketers Need to Know

Bypaulgruensfelder
Google Ads Blog May 20, 2026
Read Full Article →
AI-Generated Summary

Google is testing new AI-powered ad formats in Search, built using Gemini models, designed to make advertising more contextually relevant in AI Mode. Two new ad types are being introduced: one that surfaces product-specific details and guidance during research queries, and a second connected to merchant inventory for direct purchase pathways. The company is also expanding its Direct Offers pilot, allowing brands to deliver exclusive discounts within the Search experience. These formats are engineered to align with the conversational structure of AI Mode, where 75% of users report making faster purchase decisions. Google is also updating its visual ad tools to produce brand-aligned creative at scale using generative AI.

Why It Matters

For healthcare operators investing in Google Ads, these new AI-native formats signal a major shift in how paid search works. Understanding Gemini-driven ad placement in AI Mode will be essential for maintaining patient acquisition costs as traditional keyword-based targeting gives way to intent-driven, conversational ad delivery.

google ads AI Mode search advertising paid media generative AI patient acquisition ad formats

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Similar Posts

  • Four Forces Disrupting DSO Growth in 2026: PE, Integration, AI, and Diagnostics

    Bypaulgruensfelder

    Four major forces are reshaping DSO growth in 2026: private equity resurging in oral surgery (up 9.1% in PE deals), medical-dental integration expanding through health system partnerships, AI adoption at scale across patient communication and operations, and salivary diagnostics emerging as a clinical frontier. For DSO growth teams and PE investors, this signals where capital and clinical energy are concentrating — and what capabilities will separate market leaders from laggards through 2027.

  • The Attribution Problem Your Board Doesn’t Understand

    Bypaulgruensfelder

    Healthcare marketing attribution is genuinely hard for multi-site groups because patient journeys are long, largely offline, and privacy-constrained—and a budget you can’t defend is a budget that gets cut. Strategy Collective’s Matt Lee argues perfect attribution doesn’t exist, but ‘good enough’ attribution is achievable through four moves: call tracking, redesigned patient intake questions, a blended market-level report, and separating brand demand from generated demand. The bigger fix is reframing the board conversation itself. Instead of asking ‘is marketing working?’, leaders should ask ‘how do we make Market B look like Market A?’—shifting from an unwinnable ROI-proof debate to a comparative, market-level view that drives real reallocation decisions.

  • Q3 2026 AI Trends: What Growth Leaders Need to Track

    Bypaulgruensfelder

    The most useful AI question for growth-stage leaders in Q3 2026 has shifted from what models can do to what results they actually deliver. Summit Partners’ AI and data science team flags five developments to track: the conversation has moved from capability to production results; the binding constraint is rarely the model itself but data, workflow, and integration; agents are evolving from assistants to actors, with trust as the real limiting factor; the underlying economics of AI are being rewritten; and leaders must separate genuine signal from noise while recognizing what work stays human. The throughline is disciplined execution—turning promising pilots into dependable, measurable production systems.

  • PE’s Quieter Playbook: Joint Ventures With Nonprofit Health Systems

    Bypaulgruensfelder

    Private equity firms are increasingly expanding in healthcare through joint ventures with nonprofit health systems rather than outright buyouts, according to a new report from the Private Equity Stakeholder Project. The report finds 21.4% of private equity-owned hospitals are held through joint venture arrangements with nonprofit systems, and the structure now spans hospitals, inpatient rehab, hospice, home health, behavioral health, ambulatory surgery centers and urgent care — likely an undercount, since the tally covers only publicly identifiable arrangements. Case studies include ventures involving Lifepoint Health, Compassus, Ardent Health Services and Ascension. PESP argues these JVs have drawn far less scrutiny than traditional PE buyouts even as they become more common, prompting calls for greater oversight.

  • Why Penn Medicine Is Deploying AI Agents for Patient Intake

    Bypaulgruensfelder

    Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service, testing whether an AI ‘team member’ in the patient-provider relationship improves outcomes. The agents collect symptoms and medical history before a visit and convert them into structured summaries that feed directly into the clinician’s existing workflow — providers start appointments already informed, and patients get routed to the right level of care. The same K Health technology already runs inside virtual care programs at Cedars-Sinai, Mayo Clinic, Mass General Brigham and Hartford HealthCare, with use cases ranging from new-patient acquisition to expanding primary care access. If the pilot succeeds, Penn plans to extend the agents into in-person primary care offices and specialty clinics.

  • Health System Leaders on Costs, Innovation, and the Affordability Challenge

    Bypaulgruensfelder

    Top U.S. health system executives say affordability and cost pressure now sit at the center of nearly every strategic decision. In a Chief Healthcare Executive roundtable, leaders including Hackensack Meridian Health CEO Robert Garrett argued that systems must shift from treating illness toward preventing chronic disease and keeping communities healthy. Panelists framed innovation, particularly AI, as a double-edged force: either an ingredient in solving the affordability challenge or a threat to traditional business models. The group sees significant potential for new technology to transform operations and care delivery, while cautioning that disruption is inevitable and that executives must actively manage change rather than react to it.